Alexandria Venture Investments
Alexandria Ventures is the corporate strategic venture platform described on the source page. Since 1996 it has made direct investments in life science and agrifoodtech companies, aiming to support development of new therapeutic modalities, platforms, and agrifood technologies. The platform emphasizes deal sourcing, market insight generation, partnership development with entrepreneurs and academic institutions, and alignment with the companys tenant ecosystem.
Industries
Nr. of Employees
large (251-1000)
Alexandria Venture Investments
Products
Center for
A premier well-amenitized Megacampus offering critical proximity to innovative biopharmaceutical companies, academic and medical centers, and federal science and regulatory agencies in Maryland.
Alexandria Center for Life Science – Durham
Life science real estate offering dedicated laboratory and research facilities in Durham.
Alexandria Center for Life Science Megacampus
New York City's first and only commercial life science campus developed by Alexandria, providing a collaborative ecosystem for life science innovation and research facilities.
Alexandria Center for Science and Technology – Mission Bay
A dynamic and purpose-built Megacampus ecosystem designed to foster collaboration and innovation among its tenants with immediate proximity to the renowned UC San Francisco.
Alexandria Center for NextGen Medicines
A new collaborative campus providing custom build-to-suit opportunities for biomanufacturing and R&D companies on 95 acres of land, planned for over 1 million SF.
Alexandria Real Estate Equities
Real estate investment trust uniquely focused on collaborative Megacampus ecosystems and essential infrastructure for the life science industry.
Center for
A premier well-amenitized Megacampus offering critical proximity to innovative biopharmaceutical companies, academic and medical centers, and federal science and regulatory agencies in Maryland.
Alexandria Center for Life Science – Durham
Life science real estate offering dedicated laboratory and research facilities in Durham.
Alexandria Center for Life Science Megacampus
New York City's first and only commercial life science campus developed by Alexandria, providing a collaborative ecosystem for life science innovation and research facilities.
Alexandria Center for Science and Technology – Mission Bay
A dynamic and purpose-built Megacampus ecosystem designed to foster collaboration and innovation among its tenants with immediate proximity to the renowned UC San Francisco.
Alexandria Center for NextGen Medicines
A new collaborative campus providing custom build-to-suit opportunities for biomanufacturing and R&D companies on 95 acres of land, planned for over 1 million SF.
Alexandria Real Estate Equities
Real estate investment trust uniquely focused on collaborative Megacampus ecosystems and essential infrastructure for the life science industry.
Services
Providing direct, corporate-backed investments and strategic partnerships with companies in life sciences and agrifood technology sectors.
Providing direct, corporate-backed investments and strategic partnerships with companies in life sciences and agrifood technology sectors.
Expertise Areas
- Venture capital investment in life sciences
- Agrifoodtech investment
- Industry trend analysis for life sciences
- Partnership development and ecosystem building
Key Technologies
- Innovative therapeutic modalities
- Platform technologies for drug development
- Agrifood technology
- Venture investment and portfolio management practices
News & Updates
Ranked #1 among corporate investors in biopharma by Silicon Valley Bank by new deal volume for six consecutive years.
Ranked among the top 5 most active U.S. investors in agrifoodtech by AgFunder by number of companies invested in for three consecutive years.
Reported on-balance-sheet unrealized gains of $506 million as of December 31, 2022.
Reported adjusted cost basis of $1.2 billion for the venture portfolio as of December 31, 2022.
Ranked #1 among corporate investors in biopharma by Silicon Valley Bank by new deal volume for six consecutive years.
Ranked among the top 5 most active U.S. investors in agrifoodtech by AgFunder by number of companies invested in for three consecutive years.
Reported on-balance-sheet unrealized gains of $506 million as of December 31, 2022.
Reported adjusted cost basis of $1.2 billion for the venture portfolio as of December 31, 2022.